Looking at the Big Picture of IBD

The burden of inflammatory bowel diseases (IBD), of which Chroh's disease and ulcerative colitis are the primary entities, is significant and wide ranging. IBD that is not well-controlled impairs quality of life, social activities, travel and ability to work, leading to higher rates of absenteeism and permanent work disability.1,2 The idiopathic intestinal inflammation of IBD requires life-long treatment and accounts for enormous hospitalization costs. According to data from the U.S. Nationa...
Integritas Communications

JAK Inhibition in Rheumatoid Arthritis

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

JAK Inhibition in Inflammatory Bowel Disease

This activity has been designed to meet the educational needs of gastroenterologists and rheumatologists who care for patients with inflammatory bowel disease or rheumatoid arthritis.
Integritas Communications

JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

With increasing evidence showing that the Janus kinase (JAK) inhibition can be used as a target for certain immune-mediated diseases, this activity reviews the benefits and safety concerns gastroenterologists and rheumatologists need to consider.
Integritas Communications

Raising the Bar by Lowering the Target

This CME-accredited CME Snapshot™ highlights program compiles the key takeaways from a seven-part series intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During this activity, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience with identifying and managin...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero...
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholestero...
Integritas Communications

Diabetes Update 2019

The Comprehensive Harvard Medical School Diabetes Update This Harvard Medical School CME program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care. • Expert guidance to design comprehensive treatment programs (non-pharmacological and pharmacological) for patients with diabetes • Guidance to account for biological, psychological, emotional, social, financial and cult...
Harvard Medical School

TKI Therapy in CML: Emerging Treatments, Ensuring Safety

This Virtual Practice summarizes advances in tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) in the context of disease- and patient-specific characteristics; reviews the most effective methods for monitoring early response and long-term therapeutic outcomes; assesses the milestones and mutational analyses to identify when a change in TKI therapy is needed; compares toxicity profiles of the currently available TKI agents; and examines how toxicity could interact with...
Albert Einstein College of Medicine and RedMedEd

Managing Chronic Pain

Chronic pain management is a global health priority. Millions of adults (11%-19% of the US population) suffer daily from chronic, noncancer pain. A conservative estimate of the economic burden of pain in the US, including both healthcare costs and lost work productivity, is $560 - $635 billion annually. Most patients use a combination of non-drug approaches and medication to help alleviate pain. Although all drug treatments have risks that must be carefully weighed against the potential benefi...
The Rx Consultant

Collaborating with Patients to Reduce Long-Term Hypercholesterolemia Risks

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Tailored Lipid-Lowering Regiments for Specific Very High-Risk Profiles

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Pharmacoeconomic Outcomes of Suboptimal LDL-C Management

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Clinical Issues in Rheumatoid Arthritis: Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease that can cause bone and cartilage damage and lead to disability.1 RA affects about 24.5 million people, with 5 and 50 per 100,000 people newly developing the condition each year.1,2 RA has resulted in increased mortality in recent years, creating a need for an understanding of treat-to-target recommendations and appropriate disease activity measures.3 Adopting treat-to-target strategies in RA patients has shown great promise in ...
Integritas Communications

Update on Indications, Interactions and Complications in the Use of Pharmaceuticals Alaska Cruise

1. Drug Abuse and Misuse 2. Understanding Patient’s Approaches in Self-Care 3. Optimizing Medication Adherence and Outcomes 4. From Pharmacogenomics to Personalized Medicine 5. Comprehensive Medication Management Services 6. Pharmaceutical Regulatory Update, Key Product Approvals, Guideline Updates
Continuing Education, Inc

Primary Care Overview 2019 - Eastern Caribbean Cruise

Set sail with us aboard Holland America's newest ship, Nieuw Statendam from March 31 to April 7. This live CE, CME, CNE experience, Primary Care Overview 2019, will devote three five-hour days to learning, leaving the rest of the time for relaxation. Attendees will earn 15 contact hours (1.5 CEU) of live AAFP/AMA PRA Category 1™, ACPE, and pharmacology CE/ CME credit. Topic 1: Infectious Disease/Antibiotic Stewardship: New Antibiotics, Complicated Infections and MRSA Topic 2: Diab...
University Learning Systems

Providing Better Patient Care 2019 in Las Vegas

Join us in Las Vegas for live pharmacy CE & medical CME, vibrant nightlife, shows and fine dining. This conference, Providing Better Patient Care 2019, is hosted at the Westgate Las Vegas Resort & Casino, February 27 - March 1. This conference provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, of live AAFP/ AMA PRA Category 1™, ACPE and pharmacology CE/ CME credit. Topic 1: Update in the Management of Headaches and Seizure Disorders, Polypharmacy and the Elderly Topic...
University Learning Systems

Clinical Profiles of Current and Emerging GLP-1 RAs (Module 1 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Through Your Patient’s Eyes™ - Comprehensive Relief from Cancer Pain: Expanding the Conversation on Opioid-Induced Constipation

Despite a growing number of specific treatment options, many patients with cancer pain still suffer from opioid-induced constipation (OIC).1-3 Open communication among patients, caregivers, and treating clinicians is essential to determine the severity and psychosocial consequences of OIC.1-4 Patients with cancer pain and their proxies, however, are often reluctant to discuss opioid-related gastrointestinal symptoms and effects on quality of life. To address this barrier, clinicians should pro...
Integritas Communications

Tailoring Long-Term Maintenance Regimens for Severe Asthma

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

Guidelines on Severe Asthma: A Practical Synthesis for Specialists

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.
Integritas Communications

The Nexus of NASH and T2DM: The Emerging Role of the Diabetologist

NAFLD is a spectrum of potentially progressive liver disorders, ranging from simple hepatic steatosis to such severe forms as NASH, fibrosis, and cirrhosis.1 The prevalence rates of both NAFLD and NASH have been steadily trending upwards for years, mirroring the rapid and well-documented expansions of patient populations with obesity and/or T2DM.2-4 Thus, in the coming decade, burdens associated with this under-recognized epidemic are likely to increase exponentially for patients, clinicians, ...
Integritas Communications

Inhibition of IL-6 Signaling in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interl...
Integritas Communications

JAK Inhibitors in the Management of Rheumatoid Arthritis

This CME/CE-accredited CME Snapshot™ series of educational videos has been created for rheumatologists and other clinicians involved in treating patients with rheumatoid arthritis (RA). During each 15-minute activity, two expert rheumatologists focus on a specific aspect of long-term RA management, including practical advice on implementing international treat-to-target guidelines as well as the mechanistic profiles and clinical evidence for therapies designed to inhibit signaling via interl...
Integritas Communications

Long-term Cardiovascular Outcomes Trials With PCKS9 Inhibitors

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Novel Nonstatin LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Individualizing LDL-C Targets in High-Risk Patients

This CME-accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein choles...
Integritas Communications

Differential Diagnosis Multidisciplinary Management, and Patient Engagement (Module 4)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Patient Engagement Via Open Communication (Module 3)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Identifying Cases of Severe Asthma (Module 2)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Ask the Experts: Identifying the Needs of Patients with Severe Asthma (Module 1)

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.
Integritas Communications

Long-Term Monitoring Of Patients Treated With Intrathecal Analgesics (Module 4)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Initiating Intrathecal Therapy For Patients With Severe Chronic Pain (Module 3)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Selecting Patients Who May Benefit From Intrathecal Drug Delivery For Severe Chronic Pain (Module 2)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Overview of Intrathecal Therapy For Chronic Pain (Module 1)

This CME-accredited CME/CE Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.
Integritas Communications

Practical Recommendations for Noninsulin Injectable Therapies (Module 4 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Overcoming Barriers to Injectable Noninsulin Therapies (Module 3 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Reducing Cardiovascular Risk in Patients with T2DM (Module 2 of 4)

This CME-accredited CME Snapshot™ four-part series is intended for endocrinologists, primary care providers (PCPs), and other health care providers involved in the identification, evaluation, and treatment of patients with T2DM. During these activities, two expert faculty will participate in a series of interactive discussions on recent evidence related to glucagon-like peptide 1 receptor agonists (GLP-1 RAs). The faculty will also review freely available patient- and caregiver directed educ...
Integritas Communications

Infectious Diseases in Adults 2019

State-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses--ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: • Strateg...
Harvard Medical School

Best Practice Approaches to Prior Authorization for Your Patients with IBD: A Three-Part Series for Improving Processes and Success Rates

Much of the national healthcare debate is centered around gaining insurance coverage for more Americans, but individuals with chronic diseases know their issue is not always about having coverage – it is gaining access to treatment within their insurance coverage. Prior authorization (PA) interactions with health insurance companies can be frustrating, taking a heavy toll on clinical workflow, staff time, and patient care. Inefficient PA processes put patients with IBD at risk for poor outco...
CME Outfitters

A Team Approach to Improving Outcomes in Rheumatoid Arthritis: Clinicians, Patients, and Digital Health Coaches

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting over 1.3 million Americans and approximately 1% of the global population.1 Many treatment options are available to treat RA, and these agents may be used as monotherapy, as sequential treatment strategies, or as combination treatment. To successfully treat patients with RA, clinicians must be aware of the various treatment strategies outlined in the ACR guidelines and clinical evidence that supports these treat-to-target app...
CME Outfitters

Optimizing Immunosuppression, Precision Medicine, and Big Data: The Required Path for Innovation in Transplantation

The optimization of immunosuppression is an important modifiable risk factor that can have a positive impact on long-term outcomes in transplantation. Breakthroughs in transplant procedures and the development of more effective immunosuppressive therapies have improved patient outcomes, with short-term survival rates over 80%. However, by five years post-transplant, up to 25% of patients have returned to dialysis, and 50% of all grafts fail within 10 years. Emerging literature that supports mi...
CME Outfitters

A Better Look at Rheumatoid Arthritis: Using Imaging to Improve Patient Outcomes

This CME-accredited Point-of-Care 201™ program is intended for rheumatologists and other clinicians involved in the management of patients with rheumatoid arthritis (RA). During the video activity, two expert rheumatologists will translate the latest guidelines and clinical trial data into practical recommendations on the use of imaging modalities for the assessment of patients with RA. Topics will include reviews of various imaging techniques, use of ultrasonography to examine synovial infl...
Integritas Communications

Fact or Fiction? Sorting Out Common Misconceptions About Ulcerative Colitis to Improve Patient Care

It is well established that ulcerative colitis (UC) is a heterogeneous disease with symptoms that wane over time. The disease course for 50% of individuals is persistently active over time with worsening and relapsing symptoms and is associated with long-term anemia, colonic dysfunction, and increased risk for colorectal cancer. Evidence indicates that treating the inflammation to achieve improvement in endoscopic appearance of the mucosa early in the course of UC is effective for current flar...
CME Outfitters

Real-World Issues in HIV Prevention & Treatment: The Critical Role of the Community Pharmacist

HIV incidence in the United States has recently declined, while advances in antiretroviral therapy (ART) have improved the longevity and quality of life of many people living with HIV.1,2 Nevertheless, opportunities to expand the capacity for HIV prevention and management abound. The Centers for Disease Control and Prevention (CDC) has issued updated guidance on HIV preexposure prophylaxis (PrEP) for certain high-risk cohorts.3-5 Additionally, evidence-based guidelines related to HIV testing a...
Integritas Communications

Precision Medicine in Ankylosing Spondylitis: Fine-tuning Diagnosis and Treatment

Ankylosing spondylitis (AS) is a chronic, inflammatory arthritis that affects the axial skeleton. Due to an aging population, declining number of rheumatologists, and limited access to care, care for patients with AS is suboptimal and it is critically important that primary care can optimally recognize and manage these patients. AS is challenging to diagnose and has a 5-10 year delay in diagnosis, the longest diagnostic delay among rheumatic diseases. Studies have shown that patients with shor...
CME Outfitters

Management of Patients With Virologic Suppression: Evaluating Switching Strategies of Today and Tomorrow

This CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.
Integritas Communications

From Pathways to PROs: Translating the Latest Evidence for Current and Emerging JAK Inhibitors to Clinical Practice

Current therapeutic approaches for RA rely on disease-modifying antirheumatic drugs (DMARDs) as well as on biologic therapeutics that target tumor necrosis factor (TNF), interleukin-6 (IL-6), and T cell activation or that eliminate CD20+ B cells. These treatments have limitations, such as waning efficacy over time, side effects, and dosing inconvenience. Clinicians need to be aware of what other treatment options exist or are emerging. Further, rheumatology clinicians often face challenges in ...
CME Outfitters

Initiating HIV Therapy: Are We Now in an Integrase-Based World?

This CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.
Integritas Communications

The PROMIS® of Improved Bone Health in Older Adults

A bone-healthy lifestyle includes a diet that is rich in vitamins and nutrients, regular exercise, and avoidance of smoking and excessive alcohol intake. This, along with essential nutrients calcium and vitamin D, contribute to optimal bone health. Inadequate dietary intake of calcium and vitamin D for long periods of time can cause osteopenia, which can lead to osteoporosis as well as placing individuals at risk for falls and fractures. Fragility fractures due to osteoporosis have far-reachin...
CME Outfitters

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.